Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative vs Postoperative FLAC/G-CSF Chemotherapy in Stage II Breast Cancer
NCT00001250Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 1989
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, doxorubicin, folinic acid, cyclophosphamide, granulocyte colony-stimulating factor in breast cancer, sponsored by National Cancer Institute. Started Dec 1989; status: completed.
02
Drugs
fluorouracildoxorubicinfolinic acidcyclophosphamidegranulocyte colony-stimulating factor
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00001250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001250.